Correction: I confused myself there, thinking the initial post related to CSL's mRNA vaccine under development. It is, of course, to do with its cell based vaccine, which is not the same thing. It might be good for CSL if this vaccine at least matches Moderna's mRNA one, although probably not if Moderna's is cheaper.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$255.56 |
Change
-1.820(0.71%) |
Mkt cap ! $123.7B | |||
| Open | High | Low | Value | Volume |
| $256.32 | $256.50 | $252.60 | $90.07M | 354.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 45 | $255.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $255.58 | 15 | 2 |
View Market Depth
| Last trade - 13.47pm 21/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |